The Biology of Factor I Deficiency

The immune system relies on a complex series of checks and balances to ensure it attacks invaders without damaging your own body. In Complement Factor I (CFI) deficiency, a critical regulator in this system is missing or dysfunctional, leading to an immune response that runs out of control and severely depletes its own resources ^[1][2].

The Biology of the Alternative Pathway

The alternative pathway is a part of your immune system that is normally always active at a very low level, ready to spring into action ^[2]. When it detects a bacterium, it creates a protein called C3b, which acts like a “tag” that tells other immune cells to destroy the invader ^[3][4].

Normally, Factor I acts as a regulatory enzyme (a serine protease). Working together with required cofactors (like Factor H and CD46/MCP), it chops up C3b once the job is done, turning it into inactive fragments like iC3b ^[1][5]. Without functional Factor I, this regulation fails. The system keeps producing C3b uncontrollably, entering a feedback loop that profoundly depletes the body’s supply of the C3 protein ^[6][7]. Because your C3 reserves are so low, your body cannot efficiently “tag” new bacteria, leaving you highly vulnerable to encapsulated organisms like Neisseria meningitidis ^[8][2].

Complete Deficiency vs. Heterozygous Variants

It is highly important to distinguish between the two ways CFI mutations can be inherited, as they lead to very different medical situations:

• Complete (Biallelic) Deficiency: This occurs when a person inherits a non-working CFI gene from both parents ^[8]. This causes the primary immunodeficiency syndrome described on these pages, characterized by recurrent, life-threatening infections and chronically depleted C3 levels ^[8][6].
• Heterozygous Variants (Carriers): This occurs when a person has only one variant copy of the gene. A single variant does not uniformly produce exactly “half” normal Factor I. Instead, it acts as an incompletely penetrant susceptibility risk. Most carriers do not have a severe immunodeficiency, but depending on the specific variant and other genetic/environmental factors, it can increase the risk for conditions like atypical Hemolytic Uremic Syndrome (aHUS) or Age-Related Macular Degeneration (AMD) later in life ^[5][9][10].

The Diagnostic Process

Diagnosing this condition requires more than a single blood test. Doctors must evaluate both the amount of Factor I you have and how well it functions.

Why Levels Aren’t Enough: Type 1 vs. Type 2

• Type 1 (Quantitative): Your body does not make enough Factor I protein. Both the protein level (antigen) and the activity are low ^[11].
• Type 2 (Qualitative): Your body makes a normal amount of Factor I protein, but the protein is “broken” and cannot perform its job ^[12]. In these cases, a simple protein measurement will look normal, even though you have a complete functional deficiency. Specialized functional activity testing is required ^[12][11].

Essential Laboratory Tests

To evaluate suspected deficiency, your care team will order a “complement panel.” These tests support the diagnosis, but they are not individually diagnostic, as results can be affected by acute illness or sample handling. Typical patterns in complete deficiency include:

• Low C3: Often profoundly depleted ^[8][6].
• Normal C4: This helps distinguish it from other types of complement disorders ^[13].
• Absent/Low AP50 (Alternative Pathway activity): The alternative pathway cannot function properly ^[6][13].
• Low CH50 (Classical Pathway activity): Often reduced because the C3 required for this pathway is depleted ^[13][14].

Because complement proteins are very fragile, blood samples must be handled with extreme care. You should follow the exact collection, separation, transport, and freezing instructions provided by the specific laboratory performing the test.

Genetic Confirmation

Finally, genetic testing (specifically CFI sequencing) is used to identify the exact mutations ^[8]. In some cases, a specialized test called MLPA may be needed to find larger pieces of missing genetic material ^[15][16]. If the test returns “Variants of Uncertain Significance” (VUS), specialized immunology or genetic interpretation is required to determine if the variants actually affect Factor I function.